A text message intervention to support women's physical and mental health after breast cancer treatments (EMPOWER-SMS): a randomised controlled trial protocol

A. Singleton, S. R. Partridge, R. Raeside, M. Regimbal, K. K. Hyun, C. K. Chow, K. Sherman, E. Elder, J. Redfern

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: Breast cancer is the most common cancer diagnosed in women worldwide. In developed countries, 80-90% of women will survive five years after diagnosis but the transition from hospital-based care to health self-management and self-efficacy can be difficult. Text messaging programs offer a simple and proven way to provide support to people with chronic diseases. This study aims to test the effectiveness of a text message support program at improving women's health self-efficacy, and physical and mental health outcomes after breast cancer treatments compared to usual care at 6-months and to understand the barriers and enablers to widespread implementation. Methods: Single-blind randomised control trial (RCT; N = 160) comparing a text message support intervention to usual care in women with breast cancer (recruited from a large tertiary referral hospital in Sydney, Australia). The intervention group will receive a six-month text message support program, which consists of semi-personalised, supportive, lifestyle-focused text messages (4 messages/week) in addition to usual care. The control group will receive usual care without the text message program. Outcomes will be assessed at 6-months. The primary outcome is change in self-efficacy for managing chronic disease. Secondary outcomes include change in clinical outcomes (body mass index), lifestyle outcomes (physical activity levels, dietary behaviours), mood (depression and anxiety scales), quality of life, satisfaction with, and usefulness of the intervention. Analyses will be performed on the principle of intention-to-treat to examine differences between intervention and control groups. Discussion: This study will test if a scalable and cost-effective text-messaging intervention is effective at improving women's health self-efficacy, as well as physical and mental health outcomes. Moreover, this study will provide essential preliminary data to bolster a large multicentre RCT to helpsupport breast cancer survivors throughout recovery and beyond. Trial registration: Australia New Zealand Clinical Trials Registry (ANZCTR) number ACTRN12618002020268, 17 December 2018

LanguageEnglish
Article number660
Number of pages8
JournalBMC cancer
Volume19
Issue number1
DOIs
Publication statusPublished - 4 Jul 2019

Fingerprint

Text Messaging
Women's Health
Clinical Protocols
Mental Health
Randomized Controlled Trials
Breast Neoplasms
Self Efficacy
Therapeutics
Life Style
Chronic Disease
Single-Blind Method
Control Groups
Self Care
New Zealand
Developed Countries
Tertiary Care Centers
Survivors
Registries
Body Mass Index
Anxiety

Bibliographical note

Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • breast cancer
  • survivorship
  • support
  • text message
  • self-efficacy
  • randomised controlled trial
  • mHealth
  • translational research

Cite this

Singleton, A. ; Partridge, S. R. ; Raeside, R. ; Regimbal, M. ; Hyun, K. K. ; Chow, C. K. ; Sherman, K. ; Elder, E. ; Redfern, J. / A text message intervention to support women's physical and mental health after breast cancer treatments (EMPOWER-SMS) : a randomised controlled trial protocol. In: BMC cancer. 2019 ; Vol. 19, No. 1.
@article{26ddc67a954a43579adfbcf3b4aab7e7,
title = "A text message intervention to support women's physical and mental health after breast cancer treatments (EMPOWER-SMS): a randomised controlled trial protocol",
abstract = "Background: Breast cancer is the most common cancer diagnosed in women worldwide. In developed countries, 80-90{\%} of women will survive five years after diagnosis but the transition from hospital-based care to health self-management and self-efficacy can be difficult. Text messaging programs offer a simple and proven way to provide support to people with chronic diseases. This study aims to test the effectiveness of a text message support program at improving women's health self-efficacy, and physical and mental health outcomes after breast cancer treatments compared to usual care at 6-months and to understand the barriers and enablers to widespread implementation. Methods: Single-blind randomised control trial (RCT; N = 160) comparing a text message support intervention to usual care in women with breast cancer (recruited from a large tertiary referral hospital in Sydney, Australia). The intervention group will receive a six-month text message support program, which consists of semi-personalised, supportive, lifestyle-focused text messages (4 messages/week) in addition to usual care. The control group will receive usual care without the text message program. Outcomes will be assessed at 6-months. The primary outcome is change in self-efficacy for managing chronic disease. Secondary outcomes include change in clinical outcomes (body mass index), lifestyle outcomes (physical activity levels, dietary behaviours), mood (depression and anxiety scales), quality of life, satisfaction with, and usefulness of the intervention. Analyses will be performed on the principle of intention-to-treat to examine differences between intervention and control groups. Discussion: This study will test if a scalable and cost-effective text-messaging intervention is effective at improving women's health self-efficacy, as well as physical and mental health outcomes. Moreover, this study will provide essential preliminary data to bolster a large multicentre RCT to helpsupport breast cancer survivors throughout recovery and beyond. Trial registration: Australia New Zealand Clinical Trials Registry (ANZCTR) number ACTRN12618002020268, 17 December 2018",
keywords = "breast cancer, survivorship, support, text message, self-efficacy, randomised controlled trial, mHealth, translational research",
author = "A. Singleton and Partridge, {S. R.} and R. Raeside and M. Regimbal and Hyun, {K. K.} and Chow, {C. K.} and K. Sherman and E. Elder and J. Redfern",
note = "Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",
year = "2019",
month = "7",
day = "4",
doi = "10.1186/s12885-019-5886-8",
language = "English",
volume = "19",
journal = "BMC cancer",
issn = "1471-2407",
publisher = "Springer, Springer Nature",
number = "1",

}

A text message intervention to support women's physical and mental health after breast cancer treatments (EMPOWER-SMS) : a randomised controlled trial protocol. / Singleton, A.; Partridge, S. R.; Raeside, R.; Regimbal, M.; Hyun, K. K.; Chow, C. K.; Sherman, K.; Elder, E.; Redfern, J.

In: BMC cancer, Vol. 19, No. 1, 660, 04.07.2019.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - A text message intervention to support women's physical and mental health after breast cancer treatments (EMPOWER-SMS)

T2 - BMC cancer

AU - Singleton,A.

AU - Partridge,S. R.

AU - Raeside,R.

AU - Regimbal,M.

AU - Hyun,K. K.

AU - Chow,C. K.

AU - Sherman,K.

AU - Elder,E.

AU - Redfern,J.

N1 - Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2019/7/4

Y1 - 2019/7/4

N2 - Background: Breast cancer is the most common cancer diagnosed in women worldwide. In developed countries, 80-90% of women will survive five years after diagnosis but the transition from hospital-based care to health self-management and self-efficacy can be difficult. Text messaging programs offer a simple and proven way to provide support to people with chronic diseases. This study aims to test the effectiveness of a text message support program at improving women's health self-efficacy, and physical and mental health outcomes after breast cancer treatments compared to usual care at 6-months and to understand the barriers and enablers to widespread implementation. Methods: Single-blind randomised control trial (RCT; N = 160) comparing a text message support intervention to usual care in women with breast cancer (recruited from a large tertiary referral hospital in Sydney, Australia). The intervention group will receive a six-month text message support program, which consists of semi-personalised, supportive, lifestyle-focused text messages (4 messages/week) in addition to usual care. The control group will receive usual care without the text message program. Outcomes will be assessed at 6-months. The primary outcome is change in self-efficacy for managing chronic disease. Secondary outcomes include change in clinical outcomes (body mass index), lifestyle outcomes (physical activity levels, dietary behaviours), mood (depression and anxiety scales), quality of life, satisfaction with, and usefulness of the intervention. Analyses will be performed on the principle of intention-to-treat to examine differences between intervention and control groups. Discussion: This study will test if a scalable and cost-effective text-messaging intervention is effective at improving women's health self-efficacy, as well as physical and mental health outcomes. Moreover, this study will provide essential preliminary data to bolster a large multicentre RCT to helpsupport breast cancer survivors throughout recovery and beyond. Trial registration: Australia New Zealand Clinical Trials Registry (ANZCTR) number ACTRN12618002020268, 17 December 2018

AB - Background: Breast cancer is the most common cancer diagnosed in women worldwide. In developed countries, 80-90% of women will survive five years after diagnosis but the transition from hospital-based care to health self-management and self-efficacy can be difficult. Text messaging programs offer a simple and proven way to provide support to people with chronic diseases. This study aims to test the effectiveness of a text message support program at improving women's health self-efficacy, and physical and mental health outcomes after breast cancer treatments compared to usual care at 6-months and to understand the barriers and enablers to widespread implementation. Methods: Single-blind randomised control trial (RCT; N = 160) comparing a text message support intervention to usual care in women with breast cancer (recruited from a large tertiary referral hospital in Sydney, Australia). The intervention group will receive a six-month text message support program, which consists of semi-personalised, supportive, lifestyle-focused text messages (4 messages/week) in addition to usual care. The control group will receive usual care without the text message program. Outcomes will be assessed at 6-months. The primary outcome is change in self-efficacy for managing chronic disease. Secondary outcomes include change in clinical outcomes (body mass index), lifestyle outcomes (physical activity levels, dietary behaviours), mood (depression and anxiety scales), quality of life, satisfaction with, and usefulness of the intervention. Analyses will be performed on the principle of intention-to-treat to examine differences between intervention and control groups. Discussion: This study will test if a scalable and cost-effective text-messaging intervention is effective at improving women's health self-efficacy, as well as physical and mental health outcomes. Moreover, this study will provide essential preliminary data to bolster a large multicentre RCT to helpsupport breast cancer survivors throughout recovery and beyond. Trial registration: Australia New Zealand Clinical Trials Registry (ANZCTR) number ACTRN12618002020268, 17 December 2018

KW - breast cancer

KW - survivorship

KW - support

KW - text message

KW - self-efficacy

KW - randomised controlled trial

KW - mHealth

KW - translational research

UR - http://www.scopus.com/inward/record.url?scp=85068579246&partnerID=8YFLogxK

U2 - 10.1186/s12885-019-5886-8

DO - 10.1186/s12885-019-5886-8

M3 - Article

VL - 19

JO - BMC cancer

JF - BMC cancer

SN - 1471-2407

IS - 1

M1 - 660

ER -